TnP as a Multifaceted Therapeutic Peptide with System-Wide Regulatory Capacity.

The candidate therapeutic peptide TnP demonstrates broad, system-level regulatory capacity, revealed through integrated network analysis from transcriptomic data in zebrafish. Our study primarily identifies TnP as a multifaceted modulator of drug metabolism, wound healing, proteolytic activity, and pigmentation pathways. Transcriptomic profiling of TnP-treated larvae following tail fin amputation revealed 558 differentially expressed genes (DEGs), categorized into four functional networks: (1) drug-metabolizing enzymes (, ) and transporters (SLC/ABC families), where TnP alters xenobiotic processing through Phase I/II modulation; (2) cellular trafficking and immune regulation, with upregulated myosin genes (/) enhancing wound repair and - signaling fine-tuning inflammation; (3) proteolytic cascades (, ) coupled to autophagy (, ) and metabolic rewiring (- axis); and (4) melanogenesis-circadian networks (/-) linked to ubiquitin-mediated protein turnover. Key findings highlight TnP's unique coordination of rapid (protease activation) and sustained (metabolic adaptation) responses, enabled by short network path lengths (1.6-2.1 edges). Hub genes, such as (), , and , mediate crosstalk between these systems, while potential risks-including muscle hypercontractility ( overexpression) or cardiovascular effects (-)-underscore the need for targeted delivery. The zebrafish model validated TnP-conserved mechanisms with human relevance, particularly in drug metabolism and tissue repair. TnP's ability to synchronize extracellular matrix remodeling, immune resolution, and metabolic homeostasis supports its development for the treatment of fibrosis, metabolic disorders, and inflammatory conditions. Future work should focus on optimizing tissue-specific delivery and assessing genetic variability to advance clinical translation. This system-level analysis positions TnP as a model example for next-generation multi-pathway therapeutics.